Cover Kidney News
Volume/Issue:
Volume 15: Issue 7
Page:
8–9
Publication Date:
01 Jul 2023
Online Publication Date:
01 Jul 2023
  • 1.

    Smith RJH, et al. C3 glomerulopathy—understanding a rare complement-driven renal disease. Nat Rev Nephrol 2019; 15:129–143. doi: 10.1038/s41581-018-0107-2

  • 2.

    Fakhouri F, et al. Haemolytic uraemic syndrome. Lancet 2017; 390:681–696. doi: 10.1016/S0140-6736(17)30062-4

  • 3.

    Busutti M, et al. Efficacy of eculizumab in coexisting complement C3 glomerulopathy and atypical hemolytic uremic syndrome. Kidney Int Rep 2021; 6:534–537. doi: 10.1016/j.ekir.2020.10.037

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Chabannes M, et al. C3 glomerulopathy with concurrent thrombotic microangiopathy: Clinical and immunological features. Am J Kidney Dis (published online ahead of print April 13, 2023). doi: 10.1053/j.ajkd.2022.12.020; https://doi.org/10.1053/j.ajkd.2022.12.020

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Ravindran A, et al. Overlap of C3 glomerulopathy and thrombotic microangiopathy: A case series. Kidney Int Rep 2022; 8:619–627. doi: 10.1016/j.ekir.2022.12.009

  • 6.

    Merinero HM, et al. Complete functional characterization of disease-associated genetic variants in the complement factor H gene. Kidney Int 2018; 93:470–481. doi: 10.1016/j.kint.2017.07.015

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    McAdoo SP, et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 2017; 92:693–702. doi: 10.1016/j.kint.2017.03.014

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Schmidt T, et al. An interdisciplinary diagnostic approach to guide therapy in C3 glomerulopathy. Front Immunol 2022; 13:826513. doi: 10.3389/fimmu.2022.826513

C3 Glomerulopathy with Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features

David Vadala David Vadala, MD, and Jeffrey H. William, MD, are with the Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

Search for other papers by David Vadala in
Current site
Google Scholar
PubMed Close
and
Jeffrey H. William David Vadala, MD, and Jeffrey H. William, MD, are with the Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

Search for other papers by Jeffrey H. William in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 15: Issue 7
Publication Date:
01 Jul 2023
Page:
8–9
Restricted access
Save